FDA Inspection 1167454 — Alvaro U. Aranda, M.D.
The FDA completed an inspection of Alvaro U. Aranda, M.D. on April 13, 2022 in Guaynabo, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 13, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Guaynabo, PR (United States)
Additional Details
Clinical Investigator (CI)